Literature DB >> 15929862

Glucokinase, glucose homeostasis, and diabetes mellitus.

Franz M Matschinsky1.   

Abstract

The enzyme glucokinase (GK) regulates the rate of glucose metabolism in many tissues, including liver, the pancreatic b cells, certain neurons, enteroendocrine cells, and the pituitary, serving as a glucose sensor in many of these. Thus, GK plays a critical role in glucose homeostasis. Spontaneous mutants of GK in humans result in autosomal-dominant hypo- and hyperglycemia syndromes described as "GK disease." GK activator drugs have been discovered that lower blood glucose in normal and diabetic animals and promise to be useful in the treatment of type 2 diabetes mellitus. There is no question that the GK molecule and related issues will continue to be a fruitful topic for future research.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15929862     DOI: 10.1007/s11892-005-0005-4

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  27 in total

1.  An alternate promoter in the glucokinase gene is active in the pancreatic beta cell.

Authors:  M A Magnuson; K D Shelton
Journal:  J Biol Chem       Date:  1989-09-25       Impact factor: 5.157

2.  Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young.

Authors:  Anna L Gloyn; Stella Odili; Dorothy Zelent; Carol Buettger; Harriet A J Castleden; Anna M Steele; Amanda Stride; Chyio Shiota; Mark A Magnuson; Renata Lorini; Giuseppe d'Annunzio; Charles A Stanley; Jae Kwagh; Emile van Schaftingen; Maria Veiga-da-Cunha; Fabrizio Barbetti; Pete Dunten; Yi Han; Joseph Grimsby; Rebecca Taub; Sian Ellard; Andrew T Hattersley; Franz M Matschinsky
Journal:  J Biol Chem       Date:  2005-01-25       Impact factor: 5.157

Review 3.  Glucokinase gene structure. Functional implications of molecular genetic studies.

Authors:  M A Magnuson
Journal:  Diabetes       Date:  1990-05       Impact factor: 9.461

Review 4.  Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.

Authors:  Anna L Gloyn
Journal:  Hum Mutat       Date:  2003-11       Impact factor: 4.878

5.  Binding of sorbitol 6-phosphate and of fructose 1-phosphate to the regulatory protein of liver glucokinase.

Authors:  A Vandercammen; M Detheux; E Van Schaftingen
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

6.  Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations.

Authors:  Anna L Gloyn; Kees Noordam; Michèl A A P Willemsen; Sian Ellard; Wayne W K Lam; Ian W Campbell; Paula Midgley; Chyio Shiota; Carol Buettger; Mark A Magnuson; Franz M Matschinsky; Andrew T Hattersley
Journal:  Diabetes       Date:  2003-09       Impact factor: 9.461

7.  Identification of glucose response proteins in two biological models of beta-cell adaptation to chronic high glucose exposure.

Authors:  H Collins; H Najafi; C Buettger; J Rombeau; R G Settle; F M Matschinsky
Journal:  J Biol Chem       Date:  1992-01-15       Impact factor: 5.157

8.  Differential expression and regulation of the glucokinase gene in liver and islets of Langerhans.

Authors:  P B Iynedjian; P R Pilot; T Nouspikel; J L Milburn; C Quaade; S Hughes; C Ucla; C B Newgard
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

9.  Stimulation of hepatocyte glucose metabolism by novel small molecule glucokinase activators.

Authors:  Katy J Brocklehurst; Victoria A Payne; Rick A Davies; Debra Carroll; Helen L Vertigan; Heather J Wightman; Susan Aiston; Ian D Waddell; Brendan Leighton; Matthew P Coghlan; Loranne Agius
Journal:  Diabetes       Date:  2004-03       Impact factor: 9.461

10.  The second activating glucokinase mutation (A456V): implications for glucose homeostasis and diabetes therapy.

Authors:  Henrik B T Christesen; Bendt B Jacobsen; Stella Odili; Carol Buettger; Antonio Cuesta-Munoz; Torben Hansen; Klaus Brusgaard; Ornella Massa; Mark A Magnuson; Chiyo Shiota; Franz M Matschinsky; Fabrizio Barbetti
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

View more
  46 in total

Review 1.  Leucine metabolism in regulation of insulin secretion from pancreatic beta cells.

Authors:  Jichun Yang; Yujing Chi; Brant R Burkhardt; Youfei Guan; Bryan A Wolf
Journal:  Nutr Rev       Date:  2010-05       Impact factor: 7.110

2.  Studies on the Tissue Localization of HKDC1, a Putative Novel Fifth Hexokinase, in Humans.

Authors:  Md Wasim Khan; Xianzhong Ding; Scott J Cotler; Michael Clarke; Brian T Layden
Journal:  J Histochem Cytochem       Date:  2018-02-05       Impact factor: 2.479

3.  [Effect of intermittent fasting on physiology and gut microbiota in presenium rats].

Authors:  Zu-Hua Rong; Shao-Cong Liang; Jun-Qi Lu; Yan He; Yue-Mei Luo; Chao You; Geng-Hong Xia; Prabhakar M; Pan Li; Hong-Wei Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-04-20

4.  Dose selection using a semi-mechanistic integrated glucose-insulin-glucagon model: designing phase 2 trials for a novel oral glucokinase activator.

Authors:  Xin Zhang; Karen Schneck; Juliana Bue-Valleskey; Kwee Poo Yeo; Michael Heathman; Vikram Sinha
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-12-22       Impact factor: 2.745

5.  Tryptophan Fluorescence Yields and Lifetimes as a Probe of Conformational Changes in Human Glucokinase.

Authors:  Bogumil Zelent; Chris Bialas; Ignacy Gryczynski; Pan Chen; Rahul Chib; Karina Lewerissa; Maria G Corradini; Richard D Ludescher; Jane M Vanderkooi; Franz M Matschinsky
Journal:  J Fluoresc       Date:  2017-04-22       Impact factor: 2.217

6.  Phosphorylation of yeast hexokinase 2 regulates its nucleocytoplasmic shuttling.

Authors:  Paula Fernández-García; Rafael Peláez; Pilar Herrero; Fernando Moreno
Journal:  J Biol Chem       Date:  2012-10-12       Impact factor: 5.157

7.  Association of rs780094 in GCKR with metabolic traits and incident diabetes and cardiovascular disease: the ARIC Study.

Authors:  Mark Bi; Wen Hong Linda Kao; Eric Boerwinkle; Ron C Hoogeveen; Laura J Rasmussen-Torvik; Brad C Astor; Kari E North; Josef Coresh; Anna Köttgen
Journal:  PLoS One       Date:  2010-07-22       Impact factor: 3.240

8.  Preclinical PK/PD modeling and human efficacious dose projection for a glucokinase activator in the treatment of diabetes.

Authors:  Michael G Zager; Kirk Kozminski; Bernadette Pascual; Kathleen M Ogilvie; Shaoxian Sun
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-02-28       Impact factor: 2.745

9.  HKDC1 Is a Novel Hexokinase Involved in Whole-Body Glucose Use.

Authors:  Anton E Ludvik; Carolina M Pusec; Medha Priyadarshini; Anthony R Angueira; Cong Guo; Amy Lo; Korri S Hershenhouse; Guang-Yu Yang; Xianzhong Ding; Timothy E Reddy; William L Lowe; Brian T Layden
Journal:  Endocrinology       Date:  2016-07-26       Impact factor: 4.736

10.  Interaction effect of genetic polymorphisms in glucokinase (GCK) and glucokinase regulatory protein (GCKR) on metabolic traits in healthy Chinese adults and adolescents.

Authors:  Claudia H T Tam; Ronald C W Ma; Wing Yee So; Ying Wang; Vincent K L Lam; Soren Germer; Mitchell Martin; Juliana C N Chan; Maggie C Y Ng
Journal:  Diabetes       Date:  2008-12-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.